ISRCTN14727552已完成未知
FluCare Phase 2: Estimating the effectiveness and cost-effectiveness of a complex intervention to increase care home staff influenza vaccination rates – a feasibility study
niversity of East Anglia0 个研究点目标入组 500 人开始时间: 2021年8月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Care homes:
- •1. Long stay for older residents or dementia registration
- •2. Self-reported staff vaccination rate <40% (verified with DHSC Capacity Tracker)
- •3. Must be signed up to the DHSC Capacity Tracker and willing to provide weekly updates on flu vaccine status of staff and residents
排除标准
- •Care homes with fewer than 10 staff members
研究者
相似试验
进行中（未招募）
1 期
Estudio de fase II para evaluar la eficacia y la seguridad de la quimiorradioterapia con 5-fluorouracilo, mitomicina C y panitumumab como tratamiento del carcinoma anal de células escamosasEUCTR2010-018430-48-ESGrupo Español Multidisciplinar en cáncer Digestivo-GEMCAD
进行中（未招募）
1 期
A comparative phase2 study assessing the efficacy of triheptanoin, an anaplerotic therapy in Huntington's Disease (TRIHEP 3)Huntington's diseaseMedDRA version: 18.0Level: PTClassification code 10070668Term: Huntington's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2014-005112-42-FRINSERM50
已完成
2 期
A comparative phase2 study assessing the efficacy of triheptanoin, an anaplerotic therapy in Huntington's Disease (HD)Huntington's Diseaseneurodegenerative movement disorder1002929910028037NL-OMON43815The French National Institute of Health and Medical Research (Inserm)50
进行中（未招募）
1 期
A comparative phase2 study assessing the efficacy of triheptanoin, an anaplerotic therapy in Huntington's Disease (TRIHEP 3)Huntington's diseaseMedDRA version: 20.0Level: PTClassification code 10070668Term: Huntington's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2014-005112-42-NLINSERM100
进行中（未招募）
1 期
Phase II Study for the Evaluation of the Efficacy of Gemcitabine plus Erlotinib in Rash-positive Patients with metastatic pancreatic cancer and good risk factorsmetastatic pancreatic carcinomaMedDRA version: 18.1Level: LLTClassification code 10033576Term: Pancreas carcinomaSystem Organ Class: 100000004864EUCTR2011-005471-17-DEKlinikum der Universität München-Großhadern150